€23.64
0.00% today
Xetra, Mar 12, 10:45 am CET
ISIN
DE000BAY0017
Symbol
BAYN
Sector
Industry

Bayer Stock price

€23.64
+2.91 14.04% 1M
-3.37 12.48% 6M
+4.33 22.40% YTD
-3.18 11.86% 1Y
-31.73 57.31% 3Y
-32.43 57.84% 5Y
-117.46 83.25% 10Y
Xetra, Closing price Tue, Mar 11 2025
+0.09 0.36%
ISIN
DE000BAY0017
Symbol
BAYN
Sector
Industry

Key metrics

Market capitalization €23.22b
Enterprise Value €56.01b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 18.03
EV/Sales (TTM) EV/Sales 1.20
P/S ratio (TTM) P/S ratio 0.50
P/B ratio (TTM) P/B ratio 0.73
Dividend yield 0.47%
Last dividend (FY24) €0.11
Revenue growth (TTM) Revenue growth -2.16%
Revenue (TTM) Revenue €46.61b
EBIT (operating result TTM) EBIT €4.52b
Free Cash Flow (TTM) Free Cash Flow €3.11b
Cash position €8.09b
EPS (TTM) EPS €-2.60
P/E forward 11.03
P/S forward 0.50
EV/Sales forward 1.20
Show more

Create a Free Account to create an Bayer alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Bayer Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Bayer forecast:

4x Buy
20%
16x Hold
80%

Analyst Opinions

20 Analysts have issued a Bayer forecast:

Buy
20%
Hold
80%

Financial data from Bayer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
46,606 46,606
2% 2%
100%
- Direct Costs 21,270 21,270
8% 8%
46%
25,336 25,336
9% 9%
54%
- Selling and Administrative Expenses 10,561 10,561
2% 2%
23%
- Research and Development Expense 6,209 6,209
16% 16%
13%
8,566 8,566
29% 29%
18%
- Depreciation and Amortization 4,050 4,050
3% 3%
9%
EBIT (Operating Income) EBIT 4,516 4,516
45% 45%
10%
Net Profit -2,552 -2,552
13% 13%
-5%

In millions EUR.

Don't miss a Thing! We will send you all news about Bayer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bayer Stock News

Negative
Reuters
about 19 hours ago
Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get shareholder approval for a potential capital increase, a regulatory source told Reuters on Tuesday.
AD HOC NEWS
2 days ago
Die Privatbank Berenberg hat das Kursziel für Bayer DE000BAY0017 von 22 auf 26 Euro angehoben und die Einstufung auf "Hold" belassen.
Negative
Reuters
5 days ago
Bayer told several brokerages about plans to seek shareholder permission to issue shares one day before formally announcing the news on Friday, which weighed heavily on the stock, analysts' notes seen by Reuters showed.
More Bayer News

Company Profile

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Head office Germany
CEO William Anderson
Employees 92,815
Founded 1863
Website www.bayer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today